Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide - Duman RS.

Therapeutic medications for the treatment of depression have serious limitations, particularly delayed onset and low rates of efficacy. However, the discovery that a single subanesthetic dose of ketamine, a glutamate NMDA receptor channel blocker, can prod...

Source: SafetyLit - June 18, 2018 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news